Aldeyra Therapeutics Inc. buy marge
Start price
28.09.18
/
50%
€12.09
Target price
30.07.19
€17.14
Performance (%)
-58.96%
End price
30.07.19
€4.96
Summary
This prediction ended on 30.07.19 with a price of €4.96. Massive losses of -58.96% were the result for the BUY prediction by marge. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aldeyra Therapeutics Inc. | 0.658% | 0.658% | -36.330% | -84.120% |
| iShares Core DAX® | 0,27 % | 1,80 % | 4,85 % | 49,55 % |
| iShares Nasdaq 100 | 1,88 % | 2,15 % | 37,07 % | 87,34 % |
| iShares Nikkei 225® | 3,58 % | 5,31 % | 58,40 % | 62,32 % |
| iShares S&P 500 | 0,15 % | 1,09 % | 25,28 % | 63,88 % |
Comments by marge for this prediction
In the thread Aldeyra Therapeutics Inc. diskutieren
marge stimmt der Buy-Einschätzung von stratec zu
marge stimmt am 28.09.2018 der Buy-Einschätzung von stratec mit dem Kursziel 19$ zu.
Überschrift: Aldeyra multiple trials are set to read out in the second half of the year
(Vom Mitglied beendet)